WO2018134232A1 - Maldi device and methods of preparation and use thereof - Google Patents
Maldi device and methods of preparation and use thereof Download PDFInfo
- Publication number
- WO2018134232A1 WO2018134232A1 PCT/EP2018/051080 EP2018051080W WO2018134232A1 WO 2018134232 A1 WO2018134232 A1 WO 2018134232A1 EP 2018051080 W EP2018051080 W EP 2018051080W WO 2018134232 A1 WO2018134232 A1 WO 2018134232A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nanoparticles
- maldi
- plate
- intact
- biological entities
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 25
- 238000002360 preparation method Methods 0.000 title description 3
- 239000002105 nanoparticle Substances 0.000 claims abstract description 39
- 239000011159 matrix material Substances 0.000 claims abstract description 29
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 23
- 239000000758 substrate Substances 0.000 claims abstract description 23
- 238000004949 mass spectrometry Methods 0.000 claims abstract description 21
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 17
- 238000003795 desorption Methods 0.000 claims abstract description 12
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 6
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 6
- 150000002632 lipids Chemical class 0.000 claims abstract description 3
- 238000000816 matrix-assisted laser desorption--ionisation Methods 0.000 claims description 66
- 238000001514 detection method Methods 0.000 claims description 24
- 241000894006 Bacteria Species 0.000 claims description 22
- 206010028980 Neoplasm Diseases 0.000 claims description 16
- 201000011510 cancer Diseases 0.000 claims description 16
- 229910044991 metal oxide Inorganic materials 0.000 claims description 9
- 244000005700 microbiome Species 0.000 claims description 9
- 229910001220 stainless steel Inorganic materials 0.000 claims description 9
- 239000010935 stainless steel Substances 0.000 claims description 9
- 239000000725 suspension Substances 0.000 claims description 9
- 241000700605 Viruses Species 0.000 claims description 8
- 150000004706 metal oxides Chemical class 0.000 claims description 8
- 241000233866 Fungi Species 0.000 claims description 7
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 6
- 230000003115 biocidal effect Effects 0.000 claims description 6
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims description 4
- XOLBLPGZBRYERU-UHFFFAOYSA-N SnO2 Inorganic materials O=[Sn]=O XOLBLPGZBRYERU-UHFFFAOYSA-N 0.000 claims description 4
- MCMNRKCIXSYSNV-UHFFFAOYSA-N ZrO2 Inorganic materials O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 claims description 4
- 239000004411 aluminium Substances 0.000 claims description 4
- 229910052782 aluminium Inorganic materials 0.000 claims description 4
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 4
- 229910052751 metal Inorganic materials 0.000 claims description 4
- 239000002184 metal Substances 0.000 claims description 4
- 238000007639 printing Methods 0.000 claims description 4
- 239000006096 absorbing agent Substances 0.000 claims description 3
- 239000002800 charge carrier Substances 0.000 claims description 3
- 238000000151 deposition Methods 0.000 claims description 3
- 229910052737 gold Inorganic materials 0.000 claims description 3
- 229910052709 silver Inorganic materials 0.000 claims description 3
- 238000005245 sintering Methods 0.000 claims description 3
- 229920001940 conductive polymer Polymers 0.000 claims description 2
- 238000007641 inkjet printing Methods 0.000 claims description 2
- 239000002207 metabolite Substances 0.000 claims description 2
- 150000002739 metals Chemical class 0.000 claims description 2
- 229910052759 nickel Inorganic materials 0.000 claims description 2
- 102000039446 nucleic acids Human genes 0.000 claims description 2
- 108020004707 nucleic acids Proteins 0.000 claims description 2
- 150000007523 nucleic acids Chemical class 0.000 claims description 2
- 238000007650 screen-printing Methods 0.000 claims description 2
- -1 Ί1Ο2 Chemical class 0.000 claims description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims 1
- 238000005266 casting Methods 0.000 claims 1
- 229910052802 copper Inorganic materials 0.000 claims 1
- 239000010949 copper Substances 0.000 claims 1
- 239000011521 glass Substances 0.000 claims 1
- MRNHPUHPBOKKQT-UHFFFAOYSA-N indium;tin;hydrate Chemical compound O.[In].[Sn] MRNHPUHPBOKKQT-UHFFFAOYSA-N 0.000 claims 1
- 229910052710 silicon Inorganic materials 0.000 claims 1
- 239000010703 silicon Substances 0.000 claims 1
- 229910052725 zinc Inorganic materials 0.000 claims 1
- 239000011701 zinc Substances 0.000 claims 1
- 238000004458 analytical method Methods 0.000 abstract description 12
- 238000001906 matrix-assisted laser desorption--ionisation mass spectrometry Methods 0.000 abstract description 7
- 238000007348 radical reaction Methods 0.000 abstract description 5
- 230000027756 respiratory electron transport chain Effects 0.000 abstract description 4
- 239000003504 photosensitizing agent Substances 0.000 abstract description 3
- 210000004027 cell Anatomy 0.000 description 24
- 239000000523 sample Substances 0.000 description 22
- PCMORTLOPMLEFB-ONEGZZNKSA-N sinapic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-ONEGZZNKSA-N 0.000 description 17
- 241000588724 Escherichia coli Species 0.000 description 16
- PCMORTLOPMLEFB-UHFFFAOYSA-N sinapic acid Chemical compound COC1=CC(C=CC(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-UHFFFAOYSA-N 0.000 description 15
- 238000001819 mass spectrum Methods 0.000 description 14
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 10
- 229960000723 ampicillin Drugs 0.000 description 7
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 7
- 239000003242 anti bacterial agent Substances 0.000 description 7
- 229940088710 antibiotic agent Drugs 0.000 description 7
- 239000005090 green fluorescent protein Substances 0.000 description 7
- 229930027917 kanamycin Natural products 0.000 description 7
- 229960000318 kanamycin Drugs 0.000 description 7
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 7
- 229930182823 kanamycin A Natural products 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 239000012472 biological sample Substances 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 239000003550 marker Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 5
- AFVLVVWMAFSXCK-VMPITWQZSA-N alpha-cyano-4-hydroxycinnamic acid Chemical compound OC(=O)C(\C#N)=C\C1=CC=C(O)C=C1 AFVLVVWMAFSXCK-VMPITWQZSA-N 0.000 description 5
- 230000005660 hydrophilic surface Effects 0.000 description 5
- 150000002500 ions Chemical class 0.000 description 5
- 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 5
- 201000001441 melanoma Diseases 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 239000000090 biomarker Substances 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 230000001699 photocatalysis Effects 0.000 description 4
- 238000006479 redox reaction Methods 0.000 description 4
- 235000014469 Bacillus subtilis Nutrition 0.000 description 3
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 3
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 206010034133 Pathogen resistance Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 239000008367 deionised water Substances 0.000 description 3
- 229910021641 deionized water Inorganic materials 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 239000002086 nanomaterial Substances 0.000 description 3
- 239000010409 thin film Substances 0.000 description 3
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 2
- 241000192125 Firmicutes Species 0.000 description 2
- 229930182566 Gentamicin Natural products 0.000 description 2
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 2
- 239000004098 Tetracycline Substances 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 229960003669 carbenicillin Drugs 0.000 description 2
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 229960005091 chloramphenicol Drugs 0.000 description 2
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Natural products OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 2
- 238000003759 clinical diagnosis Methods 0.000 description 2
- 239000004020 conductor Substances 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000005684 electric field Effects 0.000 description 2
- 238000000132 electrospray ionisation Methods 0.000 description 2
- 229960003276 erythromycin Drugs 0.000 description 2
- 239000011888 foil Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 229960002518 gentamicin Drugs 0.000 description 2
- 239000012478 homogenous sample Substances 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 238000000752 ionisation method Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 238000007146 photocatalysis Methods 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 229960000268 spectinomycin Drugs 0.000 description 2
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 2
- 229960002180 tetracycline Drugs 0.000 description 2
- 229930101283 tetracycline Natural products 0.000 description 2
- 235000019364 tetracycline Nutrition 0.000 description 2
- 150000003522 tetracyclines Chemical class 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- PXRKCOCTEMYUEG-UHFFFAOYSA-N 5-aminoisoindole-1,3-dione Chemical compound NC1=CC=C2C(=O)NC(=O)C2=C1 PXRKCOCTEMYUEG-UHFFFAOYSA-N 0.000 description 1
- CDWGDLKZKCYUFO-UHFFFAOYSA-N 6-(trifluoromethyl)-1h-indole-2-carboxylic acid Chemical compound C1=C(C(F)(F)F)C=C2NC(C(=O)O)=CC2=C1 CDWGDLKZKCYUFO-UHFFFAOYSA-N 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 108090000204 Dipeptidase 1 Proteins 0.000 description 1
- 108010015899 Glycopeptides Proteins 0.000 description 1
- 102000002068 Glycopeptides Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 239000000232 Lipid Bilayer Substances 0.000 description 1
- MSFSPUZXLOGKHJ-UHFFFAOYSA-N Muraminsaeure Natural products OC(=O)C(C)OC1C(N)C(O)OC(CO)C1O MSFSPUZXLOGKHJ-UHFFFAOYSA-N 0.000 description 1
- 241000588653 Neisseria Species 0.000 description 1
- 108010013639 Peptidoglycan Proteins 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 241000607598 Vibrio Species 0.000 description 1
- 241000607734 Yersinia <bacteria> Species 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000005030 aluminium foil Substances 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 210000004666 bacterial spore Anatomy 0.000 description 1
- 239000003782 beta lactam antibiotic agent Substances 0.000 description 1
- 102000006635 beta-lactamase Human genes 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 239000000412 dendrimer Substances 0.000 description 1
- 229920000736 dendritic polymer Polymers 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000014670 detection of bacterium Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical compound [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 description 1
- 238000005040 ion trap Methods 0.000 description 1
- 150000002605 large molecules Chemical class 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000003641 microbiacidal effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229940031182 nanoparticles iron oxide Drugs 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 229910000510 noble metal Inorganic materials 0.000 description 1
- 239000012811 non-conductive material Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 238000000751 protein extraction Methods 0.000 description 1
- 230000005588 protonation Effects 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000000935 solvent evaporation Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000001269 time-of-flight mass spectrometry Methods 0.000 description 1
- 238000006276 transfer reaction Methods 0.000 description 1
- 239000000107 tumor biomarker Substances 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
Classifications
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
- H01J49/00—Particle spectrometers or separator tubes
- H01J49/02—Details
- H01J49/04—Arrangements for introducing or extracting samples to be analysed, e.g. vacuum locks; Arrangements for external adjustment of electron- or ion-optical components
- H01J49/0409—Sample holders or containers
- H01J49/0418—Sample holders or containers for laser desorption, e.g. matrix-assisted laser desorption/ionisation [MALDI] plates or surface enhanced laser desorption/ionisation [SELDI] plates
Definitions
- the present invention relates to a matrix-assisted laser desorption ionization (MALDI) target plate, comprising a conductive substrate covered with patterns of nanoparticles with a large hydrophilic surface area.
- MALDI matrix-assisted laser desorption ionization
- MALDI is a soft ionization technique used in mass spectrometry (MS), allowing analysis of biomolecules (such as DNA, proteins, peptides and sugars) 1 and large organic molecules (such as polymers and dendrimers) 2 , which are fragile and easily fragmented when ionized by other ionization methods.
- MS mass spectrometry
- MALDI is similar in character to electrospray ionization (ESI) in that both techniques use relatively soft ways of obtaining ions of large molecules in the gas phase, though MALDI produces far fewer multiply charged ions.
- the sample is mixed or overlaid with a solution of a matrix that is commonly a crystallised organic acid, acting as a light absorber and a charge carrier. After drying, the sample co-crystallises with the matrix and retains its integrity.
- the principle of MALDI ionization lies in the absorption of laser energy by the matrix (typically UV laser e.g., 337 or 355 nm), which transfers the energy to the sample and facilitates its desorption and ionization by protonation or de-protonation. 4
- the ions are then accelerated at a fixed potential, and then separated from each other on the basis of their mass-to-charge ratio (m/z).
- the charged sample is then detected and measured using one or more of mass analysers, for example quadrupole mass analysers, ion trap analysers, time of flight (TOF) analysers, etc. 5
- MALDI-TOF MS has emerged as a potential tool for analysis of biological samples such as bacteria, fungi, yeasts, viruses, tissues and cancer cells. 6 8 Due to its ability to provide information about biomolecules, such as lipids, proteins, peptides, nucleic acids and metabolites, MALDI-TOF MS has been applied for characterization and identification of micro-organisms, epidemiological studies, tissue imaging, detection of biological warfare agents, and biomarker detection, and is a powerful tool for clinical diagnosis and treatment. For example, MALDI-TOF MS has been used for bacterial identification at the genus, species and even strain levels since the pioneer work of Holland et al., 9 Claydon et al. 10 and Krishnamurthy et al. 11 in 1996. Accordingly, commercial systems, such asMALDI Biotyper ® CA (Bruker Daltonics) and VITEK ® MS (bioMerieux) have been developed for routine identification of bacteria in clinical and microbiology laboratories.
- Biological entities can be analysed by MALDI-TOF MS directly in their intact/whole state or after "preparatory" component extraction, depending on their envelope structure.
- the approach of intact sample analysis is conducted by directly spotting the sample onto a MALDI target plate and overlaying it with matrix solution. Such is the case for bacteria like Neisseria spp., Yersinia spp., and Vibrio spp., where the bacterial cells are directly physically disrupted during MS measurements. 12 ' 13 This intact sample analysis procedure is simple and fast; however, it is not always efficient.
- micro-organisms e.g., viruses, bacterial spores, yeast cells
- a combination of formic acid and acetonitrile has often been used to extract proteins from bacterial cells for MS fingerprinting.
- Matsuda et al. 15 compared the performance of both procedures for Staphylococcus spp. identification. They showed that 60.2% and 80.8% of 273 clinical strains were identified with the intact bacteria profiling method and the "preparatory" protein extraction method, respectively, while the mean process time required for 48 duplicates was 30 min for the former and 180 min for the latter.
- MALDI matrix is often dissolved in a mixture of water, organic solvents (e.g., ethanol, methanol, acetonitrile) and a strong acid (e.g., trifluoroacetic acid).
- organic solvents e.g., ethanol, methanol, acetonitrile
- a strong acid e.g., trifluoroacetic acid.
- the most frequently used matrices for biological samples are a-cyano-4- hydroxycinnamic acid (CHCA), 2,5-dihydroxy benzoic acid (DHB), and 3,5- dimethoxy-4-hydroxycinnamic acid (sinapinic acid, SA). 17
- CHCA 2,5-dihydroxy benzoic acid
- SA 3,5- dimethoxy-4-hydroxycinnamic acid
- CHCA is more suitable for detection of low molecular weight molecules such as peptides and small proteins ( ⁇ 10,000 Da); DHB is more often used for phospholipids, glycopeptides and glycoproteins ( ⁇ 10,000 Da); while SA seems to be the best choice for large proteins (> 15,000 Da).
- metal oxides e.g., TiO 2 , ZnO, ZrO 2 , SnO 2
- metal oxides doped with different metal ions e.g., Au, Ag, Co
- Their photocatalytic activity is based on their unique electronic structure, which is characterized by a filled valence band and an empty conduction band.
- metal oxide particles Upon absorption of photons from the light source, metal oxide particles generate electron-hole pairs and act as photosensitizers, which drive efficient electron-transfer reactions on their surface and produce reactive oxygen species such as hydroxyl radical ("OH), superoxide radical ( * O 2 ⁇ ), and singlet oxygen ( 1 O 2 ).
- OH hydroxyl radical
- * O 2 ⁇ superoxide radical
- singlet oxygen 1 O 2
- Nanostructures have also been used to fabricate MALDI target plates.
- the term “nanostructures” refers to structures with nanoscale size (1 - 1000 nm) in at least one dimension.
- Niu et l. 26 have proposed to produce a nanostructured thin film (such as an alumina or aluminium thin film) on a supporting plate for MALDI MS analysis of proteins, peptides, small molecules, etc.
- the nanostructured thin film was used to generate enhanced surface area and the appropriate structural dimensions.
- the present invention provides a target plate according to claim 1, for enhanced MALDI MS analysis of intact biological entities such as bacteria, fungi, yeasts, virus, tissues and cancer cells.
- the target plate comprises an electrically conductive substrate partially covered with sintered photo-reactive nanoparticles, which provide a hydrophilic surface area for homogenous sample distribution.
- the nanoparticles absorb energy from the laser to generate electron-hole pairs and act as photosensitizers. They drive electron- transfer and radical reactions and cause in-source photo-electrochemical disruption of the biological entities' envelope structure, as well as assisting in desorption and ionization of components from the entities.
- the invention can be applied for characterization and identification of micro-organisms, analysis of micro-organisms' resistance to antibiotics, detection of biomarkers, imaging of tissues, etc., and serve for quick clinical diagnosis and treatment.
- the invention also provides a method of preparing a plate, according to claim 9, and a method of use of a plate, according to claim 13.
- Optional features of the invention are set out in the dependent claims.
- Fig. 1 schematically shows a photo-reactive MALDI plate for enhanced MS analysis of intact biological entities according to the invention
- Fig. 2 shows the mass spectra of intact gram-negative bacteria Escherichia coli (E.coli) obtained using a classic bare metallic MALDI plate and a MALDI plate presented in Fig. 1;
- Fig. 3 shows the mass spectra of intact gram-positive bacteria Bacillus subtilis (B. subtilis) obtained using a classic bare metallic MALDI plate and a MALDI plate presented in Fig. 1;
- Fig. 4 shows the mass spectra of intact human melanoma cancer line wmll5 obtained using a classic bare metallic MALDI plate and a MALDI plate presented in Fig. 1;
- Fig. 5 shows the mass spectra obtained from ampicillin-resistant E.coli XL1 and ampicillin-susceptible E.coli XL1 by using a classic bare metallic MALDI plate and a MALDI plate presented in Fig. 1;
- Fig. 6 shows the mass spectra obtained from kanamycin-resistant E.coli BL21 and kanamycin-susceptible E.coli BL21 by using a classic bare metallic MALDI plate and a MALDI plate presented in Fig. 1;
- Fig. 7 shows the mass spectra obtained from melanoma cell line wmll5 with or without the expression of green fluorescent protein by using a classic bare metallic MALDI plate and a MALDI plate presented in Fig. 1.
- Fig. 1 shows a MALDI plate comprising an electrically conductive substrate 1, partially covered with immobilized photo-reactive nanoparticles 2. Nanoparticles
- a whole detection process is conducted as following: z) a sample of biological entities 3 (e.g., bacteria, fungi, yeasts, viruses, cancer cells, tissues) in their intact state is placed on the plate in contact with the nanoparticles 2, which provide a hydrophilic surface area for the homogenous sample distribution; ii) a light-sensitive organic matrix 4 is added after the sample 3 is dried at room temperature; Hi) upon irradiation by laser 5, photo-reactive nanoparticles 2 absorb the laser energy, generate electron-hole pairs and trigger redox and radical reactions.
- the envelope structure of the intact biological sample e.g., bacteria, fungi, yeasts, viruses, cancer cells, tissues
- the substrate can be a commercially available MALDI plate or a homemade target plate made of any conducting material.
- the target plate is made of aluminium, nickel, stainless steel or a conductive polymer. It can present a flat, unmodified surface, or a surface with patterned spots, dots or annular groves to assist in locating samples.
- the substrate can be made of a non- conductive material coated with a thin layer of conductive material such as one or more evaporated metals, or a semi-conducting material.
- the conducting substrate can be a metallic foil placed in contact with a commercially available MALDI plate. A foil with a thickness below 250 ⁇ is suitable, such as commercially available aluminium foil used for cooking or packaging food.
- Drops of a nanoparticle suspension are deposited on substrate 1 to form a specific area, such as a set of stripes or an array of spots.
- a specific area such as a set of stripes or an array of spots.
- the array of spots allows a high throughput analysis of biological samples and is convenient for accurate positioning of samples.
- inkjet printing, screen-printing, rotogravure printing or other deposition techniques can be used to prepare the specific area of nanoparticles.
- Several layers of a nanoparticle suspension can be deposited on the substrate to form areas of different thicknesses, ranging from 50 nanometers to 50 micrometres. After the solvent evaporation, the particles can be sintered to ensure their mutual adhesion and adhesion to the substrate.
- Sintering can be performed either by thermally heating the nanoparticles below their melting point or by low- thermal techniques such as photonic flash sintering.
- the sintered nanoparticles provide a mesoporous structure with an extremely high surface-to-volume ratio and a high hydrophilic surface for homogeneous distribution of samples.
- the nanoparticles can be metal oxides (e.g., Ti0 2 , ZnO, Zr0 2/ Sn0 2 ), metal oxides doped with different metal ions (e.g., Au, Ag, Co) and other materials with photo- catalytic activity. It is important that the band gap of the nanoparticles matches the laser wavelength in the MALDI mass spectrometer.
- the sample can include whole or intact micro-organisms (e.g., bacteria, fungi, yeasts, virus), cells (e.g., cancer cells), tissues, or any other biological entities. If the sample is suspended in a liquid solution it can be deposited dropwise on the plate. If the sample is in a solid state it can be directly placed on the plate.
- micro-organisms e.g., bacteria, fungi, yeasts, virus
- cells e.g., cancer cells
- tissues e.g., or any other biological entities.
- the light sensitive organic matrix 4 can be a classic MALDI matrix containing usually a crystalline acid, such as a-cyano-4-hydroxycinnamic acid (CHCA), sinapic acid (SA), 2,5-dihydroxybenzoic acid (DHB) or 2-(4-hydroxyphenylazo)- benzoic acid (HABA).
- a crystalline acid such as a-cyano-4-hydroxycinnamic acid (CHCA), sinapic acid (SA), 2,5-dihydroxybenzoic acid (DHB) or 2-(4-hydroxyphenylazo)- benzoic acid (HABA).
- CHCA a-cyano-4-hydroxycinnamic acid
- SA sinapic acid
- DVB 2,5-dihydroxybenzoic acid
- HABA 2-(4-hydroxyphenylazo)- benzoic acid
- the gist of the present invention is to use photo-reactive nanoparticles for in- source photo-electrochemical disruption of the envelope of intact biological entities and for desorption/ ionization of the entities' components in the presence of an organic matrix.
- Samples are homogeneously distributed and adsorbed on the hydrophilic surface of nanoparticles. Under the irradiation of a pulsed laser light, the nanoparticles absorb energy from the laser, generate electron-hole pairs, and induce electron-transfer and radical reactions. These reactions cause break-up of the analysed entities, facilitating desorption and ionization of inner components together with the assistance of the matrix.
- Fig. 2 shows the comparison of mass spectra obtained from intact gram-negative bacteria E.coli by using a classic stainless steel MALDI plate and a photo-reactive MALDI plate from Fig. 1 where the immobilized nanoparticles 2 are ⁇ 1 ⁇ 2.
- Sinapinic acid was used as the organic matrix.
- Fig. 2a is in the mass range m/z 6,000 - 15,000 and Fig. 2b is for m/z 15,000 - 34,000.
- the obtained results show that the photo-reactive MALDI plate brings more relevant information from intact gram-negative bacteria.
- Fig. 3 shows the comparison of mass spectra obtained from intact gram-positive bacteria B.subtilis by using a classic stainless steel MALDI plate and a photo- reactive MALDI plate from Fig. 1 where the immobilized nanoparticles 2 are T1O2.
- Sinapinic acid was used as the organic matrix.
- Fig. 3a is in the mass range m/z 6,000 - 12,000 and Fig. 3b is for m/z 12,000 - 34,000.
- the obtained results show that photo-reactive MALDI plate brings more relevant information from intact gram- positive bacteria.
- Figs. 2 and 3 imply that identification of bacteria on the basis of protein fingerprinting can be significantly improved by using the present invention, especially at high mass range (m/z > 10,000).
- Fig. 4 shows the comparison of mass spectra obtained from the intact human melanoma cell line ivmll5 by using a classic stainless steel MALDI plate and a photo-reactive MALDI plate from Fig. 1 where the immobilised nanoparticles 2 are T1O2.
- Sinapinic acid was used as the organic matrix.
- Fig. 4a is in the mass range m/z 5,000 - 15,000 and Fig. 4b is for m/z 15,000 - 50,000.
- the obtained results show that more peaks can be obtained with the photo-reactive MALDI plate, implying that more components, especially with high molecular weight (> 10,000 Da) can be detected from intact cancer cells with the present invention.
- Fig. 5 compares the performance of a classic stainless steel MALDI plate (Fig. 5a) and a plate from Fig. 1 where the nanoparticles 2 are ⁇ 2 (Fig. 5b) for detection of bacterial resistance to ampicillin.
- the mass spectrum obtained from ampicillin-resistant E.coli XL1 was compared with that from ampicillin-susceptible E.coli XL1 at the mass range of m/z 27,800 - 29,800.
- Sinapinic acid was used as the organic matrix.
- the ampicillin-resistance gene expressed as a protein of 28,970 Da, was detected from the resistant strain using the invented plate (Fig. 5b), whereas this gene is undetectable using a classic bare MALDI plate (Fig. 5a).
- Fig. 6 compares the performance of a classic stainless steel MALDI plate (Fig. 6a) and a plate from Fig. 1 where the immobilised nanoparticles 2 are Ti0 2 (Fig. 6b) for detection of bacterial resistance to kanamycin.
- Fig. 6a and Fig. 6b the mass spectrum obtained from kanamycin-resistant E.coli BL21 was compared with that from kanamycin-susceptible E.coli BL21 at the mass range of m/z 19,000 - 20,000.
- Sinapinic acid was used as organic matrix.
- the kanamycin-resistance gene expressed as a protein of 29,050 Da, was detected from the resistant strain with the invented plate (Fig.
- Fig. 7 compares the performance of a classic stainless steel MALDI plate (Fig. 7a) and a plate from Fig. 1 where the immobilized nanoparticles 2 are Ti0 2 (Fig. 7b), for detection of a specific marker from cancer cells. In both Fig. 7a and Fig.
- the invented device can produce highly reproducible results, as the disruption process of the entities depends only on the photo-reactive nanomaterial.
- this invention provides a quick way of precise profiling of biological entities with high reproducibility. It therefore helps to broaden the applications of MALDI MS for biochemical research and clinical medicine.
- a ⁇ 1 ⁇ 2 suspension is prepared by dissolving a commercially available T1O2 paste (Solaronix Ti-Nanoxide D20/SP, Switzerland, 20 - 25 nm anatase nanoparticles; suspension Visopropanoi/Vwater/VTriton x-100 78/19.5/2.5) to reach a final concentration of 0.2 % (m/ m).
- T1O2 paste Small Organic Chemical Vapent
- the T1O2 suspension can also be screen-printed, rotogravure-printed, or directly deposited with a micropipette (1-10 ⁇ ,) onto the metal substrate.
- Bacteria e.g., E.coli, B.sutilis
- antibiotics e.g., ampicillin, carbenicillin, kanamycin, chloramphenicol, gentamicin, spectinomycin, erythromycin, hygromycin, tetracycline, etc.
- the solution (1 - 2 L) is deposited with a micropipette onto a spot on the Ti02-modified target plate, and dried at room temperature ( ⁇ 5 min).
- Matrix solution (1 - 2 uL, sinapinic acid, 15 mg/mL in Vacetonitriie/Vwater/ Vtrifluoroacetic acid 50/ 49.5/0.1) is added to cover the bacteria sample spot and dried at room temperature ( ⁇ 5 min).
- MALDI-TOF MS detection was performed on a Bruker microflex ® LRF under linear positive mode.
- the laser source used in this instrument is a nitrogen laser (337.1 nm).
- One mass spectrum is obtained from each sample spot by accumulation of 500 laser shots. Each test is repeated for 3 times and the average mass spectrum is presented in all figures.
- Non-pathogenic gram-negative E.coli and gram-positive B.subtilis are used as models to investigate the performance of the invented T1O2-MALDI plate for intact bacteria profiling and compare it with a classic bare MALDI plate. Results show that more peaks are obtained from the invented T1O2-MALDI plate, especially at the mass range > 10,000 Da, as shown in Fig. 2 and Fig. 3.
- the bacterial envelope is mainly composed of lipid bilayers and peptidoglycan, which can be broken up by TiO2-induced photo-chemical redox reactions.
- the ⁇ 2 nanoparticles also facilitate desorption and ionization of inner components together with the presence of organic matrix. Accordingly, more information about the internal components can be produced by the T1O2-MALDI plate directly from intact bacteria.
- Antibiotic-resistant bacteria often contain special resistance genes in their genome or on plasmids, which they have acquired from other bacteria and which they can spread to make non-resistant bacteria resistant to specific antibiotic compounds. Such antibiotic resistance genes encode proteins that perform enzymatic reactions to degrade or modify antibiotic molecules making them non-functional. These proteins conferring resistance to antibiotics normally appear in the mass range higher than 10,000 Da. Ampicillin and kanamycin resistance of E.coli are firstly analysed as models. As shown in Fig. 5b, compared to the ampicillin-susceptible E.coli XLl-blue strain, an additional peak at m/z 28,970 is detected from the ampicillin-resistant strain, by using the invented Ti02-MALDI plate.
- E.coli strains In addition to ampicillin and kanamycin, the resistance of E.coli strains to other antibiotics (e.g. carbenicillin, chloramphenicol, gentamicin, spectinomycin, erythromycin, hygromycin, tetracycline, etc.) can also be detected by the invented plate from intact bacteria.
- antibiotics e.g. carbenicillin, chloramphenicol, gentamicin, spectinomycin, erythromycin, hygromycin, tetracycline, etc.
- the human melanoma cell line wmll5 is employed as model.
- a cell pellet is collected from culture media by centrifugation (2,000 rpm x 4 min), and resuspended in the same volume of deionized water.
- the solution (1 pL) is deposited onto a T1O2 spot on the target plate and dried at room temperature.
- the cells are covered by 1 iL of matrix solution (sinapinic acid, 15 mg/ mL in Vacetonitriie/Vwater/Vtrifiuoroacetic acid 50/49.5/0.1) and dried at room temperature prior MALDI MS detection. MS measurements are similar to those of Example 1.
Landscapes
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Abstract
A target plate for enhanced matrix-assisted laser desorption/ionization mass spectrometry (MALDI MS) analysis of intact biological entities. The target plate comprises an electrically conductive substrate (1) covered at least partially with immobilised photo-reactive nanoparticles (2), acting as a photosensitizer and an ionization device, which drives efficient electron-transfer and radical reactions causing in-source disruption of the envelope structure of intact biological entities (3) and helps in desorption/ionization of components such as lipids, peptides and proteins from the intact biological entities to the MS analyser.
Description
MALDI DEVICE AND METHODS OF PREPARATION AND USE THEREOF
Background to the Invention The present invention relates to a matrix-assisted laser desorption ionization (MALDI) target plate, comprising a conductive substrate covered with patterns of nanoparticles with a large hydrophilic surface area.
MALDI is a soft ionization technique used in mass spectrometry (MS), allowing analysis of biomolecules (such as DNA, proteins, peptides and sugars)1 and large organic molecules (such as polymers and dendrimers)2, which are fragile and easily fragmented when ionized by other ionization methods. MALDI is similar in character to electrospray ionization (ESI) in that both techniques use relatively soft ways of obtaining ions of large molecules in the gas phase, though MALDI produces far fewer multiply charged ions.3
In a typical MALDI MS detection, the sample is mixed or overlaid with a solution of a matrix that is commonly a crystallised organic acid, acting as a light absorber and a charge carrier. After drying, the sample co-crystallises with the matrix and retains its integrity. The principle of MALDI ionization lies in the absorption of laser energy by the matrix (typically UV laser e.g., 337 or 355 nm), which transfers the energy to the sample and facilitates its desorption and ionization by protonation or de-protonation. 4 The ions are then accelerated at a fixed potential, and then separated from each other on the basis of their mass-to-charge ratio (m/z). The charged sample is then detected and measured using one or more of mass analysers, for example quadrupole mass analysers, ion trap analysers, time of flight (TOF) analysers, etc.5
In recent years, MALDI-TOF MS has emerged as a potential tool for analysis of biological samples such as bacteria, fungi, yeasts, viruses, tissues and cancer
cells.6 8 Due to its ability to provide information about biomolecules, such as lipids, proteins, peptides, nucleic acids and metabolites, MALDI-TOF MS has been applied for characterization and identification of micro-organisms, epidemiological studies, tissue imaging, detection of biological warfare agents, and biomarker detection, and is a powerful tool for clinical diagnosis and treatment. For example, MALDI-TOF MS has been used for bacterial identification at the genus, species and even strain levels since the pioneer work of Holland et al.,9 Claydon et al.10 and Krishnamurthy et al.11 in 1996. Accordingly, commercial systems, such asMALDI Biotyper ® CA (Bruker Daltonics) and VITEK ® MS (bioMerieux) have been developed for routine identification of bacteria in clinical and microbiology laboratories.
Biological entities can be analysed by MALDI-TOF MS directly in their intact/whole state or after "preparatory" component extraction, depending on their envelope structure. The approach of intact sample analysis is conducted by directly spotting the sample onto a MALDI target plate and overlaying it with matrix solution. Such is the case for bacteria like Neisseria spp., Yersinia spp., and Vibrio spp., where the bacterial cells are directly physically disrupted during MS measurements.12 ' 13 This intact sample analysis procedure is simple and fast; however, it is not always efficient. For more resistant micro-organisms (e.g., viruses, bacterial spores, yeast cells), it is necessary to first extract the components from the entities and deposit the extractions on a target plate for MS measurements. For example, a combination of formic acid and acetonitrile has often been used to extract proteins from bacterial cells for MS fingerprinting.14 Compared to intact sample analysis, the "preparatory" component extraction procedure can provide more sample information, but is much more time- consuming. Matsuda et al.15 compared the performance of both procedures for Staphylococcus spp. identification. They showed that 60.2% and 80.8% of 273 clinical strains were identified with the intact bacteria profiling method and the "preparatory" protein extraction method, respectively, while the mean process
time required for 48 duplicates was 30 min for the former and 180 min for the latter.
MALDI matrix is often dissolved in a mixture of water, organic solvents (e.g., ethanol, methanol, acetonitrile) and a strong acid (e.g., trifluoroacetic acid).16 The most frequently used matrices for biological samples are a-cyano-4- hydroxycinnamic acid (CHCA), 2,5-dihydroxy benzoic acid (DHB), and 3,5- dimethoxy-4-hydroxycinnamic acid (sinapinic acid, SA).17 The choice of matrix depends on the mass range analysed and the type of information wanted from the samples. Normally, CHCA is more suitable for detection of low molecular weight molecules such as peptides and small proteins (< 10,000 Da); DHB is more often used for phospholipids, glycopeptides and glycoproteins (< 10,000 Da); while SA seems to be the best choice for large proteins (> 15,000 Da).18
It has been reported that metal oxides (e.g., TiO2, ZnO, ZrO2, SnO2) and metal oxides doped with different metal ions (e.g., Au, Ag, Co) have microbicidal effects by photocatalysis.19-22 Their photocatalytic activity is based on their unique electronic structure, which is characterized by a filled valence band and an empty conduction band. Upon absorption of photons from the light source, metal oxide particles generate electron-hole pairs and act as photosensitizers, which drive efficient electron-transfer reactions on their surface and produce reactive oxygen species such as hydroxyl radical ("OH), superoxide radical (*O2 ~), and singlet oxygen (1O2). These reactive species can break up the envelope structure of microorganisms by photo-electrochemical disruption that leads to release of inner components. For example, it has been demonstrated that TiO2 can kill gram- positive/negative bacteria, viruses, fungi, and even cancer cells in aqueous solutions by photocatalysis.23
Metal oxides and noble metals have been proposed to modify the surface of MALDI target plates. Due to their ability of absorbing energy from laser source, transferring energy to samples and assisting desorption/ ionization of samples, they can replace often used organic matrices for MS detection and also can be used for in-source tagging reactions, disulfide bridge reductions or ion source decay reactions.24 ' 25 The modified target plates are usually called surface-assisted laser desorption/ ionization (SALDI) plates.
Nanostructures have also been used to fabricate MALDI target plates. The term "nanostructures" refers to structures with nanoscale size (1 - 1000 nm) in at least one dimension. For example, Niu et l.26 have proposed to produce a nanostructured thin film (such as an alumina or aluminium thin film) on a supporting plate for MALDI MS analysis of proteins, peptides, small molecules, etc. The nanostructured thin film was used to generate enhanced surface area and the appropriate structural dimensions.
Summary of the Invention
The present invention provides a target plate according to claim 1, for enhanced MALDI MS analysis of intact biological entities such as bacteria, fungi, yeasts, virus, tissues and cancer cells. The target plate comprises an electrically conductive substrate partially covered with sintered photo-reactive nanoparticles, which provide a hydrophilic surface area for homogenous sample distribution. During MALDI MS detection, the nanoparticles absorb energy from the laser to generate electron-hole pairs and act as photosensitizers. They drive electron- transfer and radical reactions and cause in-source photo-electrochemical disruption of the biological entities' envelope structure, as well as assisting in desorption and ionization of components from the entities. Compared to the usage of classic bare metallic MALDI target plates, more sample components, especially large proteins (> 10,000 Da) or low-abundant biomolecules, can be
detected using the target plate of this invention. It is an efficient tool for rapid profiling of biological entities without the need for "preparatory" component extraction. The invention can be applied for characterization and identification of micro-organisms, analysis of micro-organisms' resistance to antibiotics, detection of biomarkers, imaging of tissues, etc., and serve for quick clinical diagnosis and treatment.
The invention also provides a method of preparing a plate, according to claim 9, and a method of use of a plate, according to claim 13. Optional features of the invention are set out in the dependent claims.
Brief Description of the Drawings
Embodiments of the invention will now be described in more detail, by way of example only, with reference to the accompanying drawings, in which:
Fig. 1 schematically shows a photo-reactive MALDI plate for enhanced MS analysis of intact biological entities according to the invention; Fig. 2 shows the mass spectra of intact gram-negative bacteria Escherichia coli (E.coli) obtained using a classic bare metallic MALDI plate and a MALDI plate presented in Fig. 1;
Fig. 3 shows the mass spectra of intact gram-positive bacteria Bacillus subtilis (B. subtilis) obtained using a classic bare metallic MALDI plate and a MALDI plate presented in Fig. 1;
Fig. 4 shows the mass spectra of intact human melanoma cancer line wmll5 obtained using a classic bare metallic MALDI plate and a MALDI plate presented in Fig. 1;
Fig. 5 shows the mass spectra obtained from ampicillin-resistant E.coli XL1 and ampicillin-susceptible E.coli XL1 by using a classic bare metallic MALDI plate and a MALDI plate presented in Fig. 1;
Fig. 6 shows the mass spectra obtained from kanamycin-resistant E.coli BL21 and kanamycin-susceptible E.coli BL21 by using a classic bare metallic MALDI plate and a MALDI plate presented in Fig. 1; Fig. 7 shows the mass spectra obtained from melanoma cell line wmll5 with or without the expression of green fluorescent protein by using a classic bare metallic MALDI plate and a MALDI plate presented in Fig. 1.
Detailed Description of Particular Embodiments
Fig. 1 shows a MALDI plate comprising an electrically conductive substrate 1, partially covered with immobilized photo-reactive nanoparticles 2. Nanoparticles
2 act as sensitive photo-reactive materials and an ionization device when covered by an organic matrix. A whole detection process is conducted as following: z) a sample of biological entities 3 (e.g., bacteria, fungi, yeasts, viruses, cancer cells, tissues) in their intact state is placed on the plate in contact with the nanoparticles 2, which provide a hydrophilic surface area for the homogenous sample distribution; ii) a light-sensitive organic matrix 4 is added after the sample 3 is dried at room temperature; Hi) upon irradiation by laser 5, photo-reactive nanoparticles 2 absorb the laser energy, generate electron-hole pairs and trigger redox and radical reactions. The envelope structure of the intact biological sample
3 is disrupted by these reactions leading to exposure of sample's components 6; iv) components 6 are desorbed from sample 3 and ionized with the assistance of photo-reactive nanoparticles 2 and organic matrix 4, released into the gas phase and driven by an electric field to the analyser of a mass spectrometer.
Substrate 1 in Fig. V.
The substrate can be a commercially available MALDI plate or a homemade target plate made of any conducting material. Typically, the target plate is made of aluminium, nickel, stainless steel or a conductive polymer. It can present a flat, unmodified surface, or a surface with patterned spots, dots or annular groves to assist in locating samples. Alternatively, the substrate can be made of a non- conductive material coated with a thin layer of conductive material such as one or more evaporated metals, or a semi-conducting material. Also, the conducting substrate can be a metallic foil placed in contact with a commercially available MALDI plate. A foil with a thickness below 250 μιη is suitable, such as commercially available aluminium foil used for cooking or packaging food. When carrying out MALDI detection, a high voltage is applied to the substrate with respect to the mass spectrometer. The electric field thereby generated drives the ions released upon energy absorption to the analyser of the mass spectrometer.
Photo-reactive nanoparticles 2 in Fig. 1:
Drops of a nanoparticle suspension are deposited on substrate 1 to form a specific area, such as a set of stripes or an array of spots. Usually, the array of spots allows a high throughput analysis of biological samples and is convenient for accurate positioning of samples. Alternatively, inkjet printing, screen-printing, rotogravure printing or other deposition techniques can be used to prepare the specific area of nanoparticles. Several layers of a nanoparticle suspension can be deposited on the substrate to form areas of different thicknesses, ranging from 50 nanometers to 50 micrometres. After the solvent evaporation, the particles can be sintered to ensure their mutual adhesion and adhesion to the substrate. Sintering can be performed either by thermally heating the nanoparticles below their melting point or by low- thermal techniques such as photonic flash sintering. The sintered nanoparticles provide a mesoporous structure with an extremely high surface-to-volume ratio and a high hydrophilic surface for homogeneous distribution of samples. The
nanoparticles can be metal oxides (e.g., Ti02, ZnO, Zr02/ Sn02), metal oxides doped with different metal ions (e.g., Au, Ag, Co) and other materials with photo- catalytic activity. It is important that the band gap of the nanoparticles matches the laser wavelength in the MALDI mass spectrometer.
Biological sample 3 in Fig. V.
The sample can include whole or intact micro-organisms (e.g., bacteria, fungi, yeasts, virus), cells (e.g., cancer cells), tissues, or any other biological entities. If the sample is suspended in a liquid solution it can be deposited dropwise on the plate. If the sample is in a solid state it can be directly placed on the plate.
Light sensitive organic matrix 4 in Fig. 1:
The light sensitive organic matrix 4 can be a classic MALDI matrix containing usually a crystalline acid, such as a-cyano-4-hydroxycinnamic acid (CHCA), sinapic acid (SA), 2,5-dihydroxybenzoic acid (DHB) or 2-(4-hydroxyphenylazo)- benzoic acid (HABA). The acid plays the role of a light absorber and a charge carrier, assisting desorption/ ionization of components from sample 3.
Photoionization process:
The gist of the present invention is to use photo-reactive nanoparticles for in- source photo-electrochemical disruption of the envelope of intact biological entities and for desorption/ ionization of the entities' components in the presence of an organic matrix. Samples are homogeneously distributed and adsorbed on the hydrophilic surface of nanoparticles. Under the irradiation of a pulsed laser light, the nanoparticles absorb energy from the laser, generate electron-hole pairs, and induce electron-transfer and radical reactions. These reactions cause break-up of the analysed entities, facilitating desorption and ionization of inner components together with the assistance of the matrix.
Results
Fig. 2 shows the comparison of mass spectra obtained from intact gram-negative bacteria E.coli by using a classic stainless steel MALDI plate and a photo-reactive MALDI plate from Fig. 1 where the immobilized nanoparticles 2 are Ί1Ο2. Sinapinic acid was used as the organic matrix. Fig. 2a is in the mass range m/z 6,000 - 15,000 and Fig. 2b is for m/z 15,000 - 34,000. The obtained results show that the photo-reactive MALDI plate brings more relevant information from intact gram-negative bacteria.
Fig. 3 shows the comparison of mass spectra obtained from intact gram-positive bacteria B.subtilis by using a classic stainless steel MALDI plate and a photo- reactive MALDI plate from Fig. 1 where the immobilized nanoparticles 2 are T1O2. Sinapinic acid was used as the organic matrix. Fig. 3a is in the mass range m/z 6,000 - 12,000 and Fig. 3b is for m/z 12,000 - 34,000. The obtained results show that photo-reactive MALDI plate brings more relevant information from intact gram- positive bacteria. Figs. 2 and 3 imply that identification of bacteria on the basis of protein fingerprinting can be significantly improved by using the present invention, especially at high mass range (m/z > 10,000).
Fig. 4 shows the comparison of mass spectra obtained from the intact human melanoma cell line ivmll5 by using a classic stainless steel MALDI plate and a photo-reactive MALDI plate from Fig. 1 where the immobilised nanoparticles 2 are T1O2. Sinapinic acid was used as the organic matrix. Fig. 4a is in the mass range m/z 5,000 - 15,000 and Fig. 4b is for m/z 15,000 - 50,000. The obtained results show that more peaks can be obtained with the photo-reactive MALDI plate, implying that more components, especially with high molecular weight (> 10,000 Da) can be detected from intact cancer cells with the present invention.
Fig. 5 compares the performance of a classic stainless steel MALDI plate (Fig. 5a) and a plate from Fig. 1 where the nanoparticles 2 are ΉΟ2 (Fig. 5b) for detection of
bacterial resistance to ampicillin. In both Fig. 5a and Fig. 5b, the mass spectrum obtained from ampicillin-resistant E.coli XL1 was compared with that from ampicillin-susceptible E.coli XL1 at the mass range of m/z 27,800 - 29,800. Sinapinic acid was used as the organic matrix. The ampicillin-resistance gene, expressed as a protein of 28,970 Da, was detected from the resistant strain using the invented plate (Fig. 5b), whereas this gene is undetectable using a classic bare MALDI plate (Fig. 5a).
Fig. 6 compares the performance of a classic stainless steel MALDI plate (Fig. 6a) and a plate from Fig. 1 where the immobilised nanoparticles 2 are Ti02 (Fig. 6b) for detection of bacterial resistance to kanamycin. In both Fig. 6a and Fig. 6b, the mass spectrum obtained from kanamycin-resistant E.coli BL21 was compared with that from kanamycin-susceptible E.coli BL21 at the mass range of m/z 19,000 - 20,000. Sinapinic acid was used as organic matrix. The kanamycin-resistance gene, expressed as a protein of 29,050 Da, was detected from the resistant strain with the invented plate (Fig. 6b), whereas the product of this gene is undetectable with a classic bare MALDI plate (Fig. 6a). Fig. 5 and Fig. 6 imply potential applications of the present invention for fast detection of bacterial resistance to antibiotics. Fig. 7 compares the performance of a classic stainless steel MALDI plate (Fig. 7a) and a plate from Fig. 1 where the immobilized nanoparticles 2 are Ti02 (Fig. 7b), for detection of a specific marker from cancer cells. In both Fig. 7a and Fig. 7b, the mass spectra obtained from intact human melanoma cell wmll5 with and without the GFP marker (green fluorescent protein, Mw ^ 26,900 Da) were compared at the mass range of m/z 25,000 - 29,000. Sinapinic acid was used as the organic matrix. In Fig. 7b, a peak around m/z 26,900 is clearly detected from GFP- expressed wmll5 with high intensity and resolution using the invented plate, while this marker is hardly detected using the classic bare MALDI plate (Fig. 7a). This finding implies that the present invention is advantageous in detecting biomarkers from cancer cells.
Advantages of the present work
To study biological samples such as micro-organisms, cells and tissues by mass spectrometry, two procedures are usually adopted. One is to directly place intact entities on a classic bare MALDI plate for MS detection; the other one includes "preparatory" component extraction prior to MS detection. The former is simple and fast, but may not be always sufficient for biological analysis. The latter can provide more sample information, but is time-consuming; also, the extracted components vary greatly with the extraction protocol. Herein, using the present invention, biological entities on the target plate undergo an in-source photo- induced electrochemical disruption process during MALDI detection, with their envelope structures being broken up by redox and radical reactions. This invented device also enhances the desorption/ ionization process of the entities' components. Accordingly, more components (especially large molecular weight proteins or low-abundant molecules) can be detected directly from intact entities. Moreover, different redox proton donor/ acceptor probes (such as salicylic acid or dopamine) could be added to the matrix to promote proton transfer and redox reactions. Additionally, with fixed MALDI detection parameters, the invented device can produce highly reproducible results, as the disruption process of the entities depends only on the photo-reactive nanomaterial. Generally, this invention provides a quick way of precise profiling of biological entities with high reproducibility. It therefore helps to broaden the applications of MALDI MS for biochemical research and clinical medicine. Examples
Example 1 - Detection of Bacteria Resistance to Antibiotics Using TiOi-modified MALDI Target Plates
Fabrication of TiQ2-modified Target Plate
An aluminium plate or a stainless steel plate is used as a substrate. A Ί1Ο2 suspension is prepared by dissolving a commercially available T1O2 paste (Solaronix Ti-Nanoxide D20/SP, Switzerland, 20 - 25 nm anatase nanoparticles; suspension Visopropanoi/Vwater/VTriton x-100 78/19.5/2.5) to reach a final concentration of 0.2 % (m/ m). The obtained suspension is inkjet-printed using a disposable cartridge DMC-11610 (Dimatix Fujifilm, USA) containing 16 individually addressable nozzles with 10 pL nominal droplet volume, forming an array of spots (3 mm diameter) on the substrate. An optimum substrate temperature of 60 °C is used during the printing, ensuring rapid drying of the ink on the substrate and good printing resolution. Afterwards, the printed plate is heated at 400 °C for one hour to sinter the nanoparticles and then cooled down to room temperature. The T1O2 suspension can also be screen-printed, rotogravure-printed, or directly deposited with a micropipette (1-10 μΐ,) onto the metal substrate.
Preparation of Bacteria Samples
Bacteria (e.g., E.coli, B.sutilis) resistant or susceptible to different antibiotics, (e.g., ampicillin, carbenicillin, kanamycin, chloramphenicol, gentamicin, spectinomycin, erythromycin, hygromycin, tetracycline, etc.) are separated from the growing media by centrifugation (13,000 rpm x 3 min), and washed three times with deionized water. Finally, the pellet is resuspended in deionized water with the concentration around 108 cells mL . The solution (1 - 2 L) is deposited with a micropipette onto a spot on the Ti02-modified target plate, and dried at room temperature (~ 5 min). All practical activities with bacteria and antibiotics are conducted in a biosafety level 1 or 2 (PI or P2) laboratory. All wastes are autoclaved and disposed properly according to the safety guidelines. Instruments, facilities and benches are wiped with ethanol 70% /water 30% when activities are finished.
MALDI Matrix Deposition and MS Measurements
Matrix solution (1 - 2 uL, sinapinic acid, 15 mg/mL in Vacetonitriie/Vwater/ Vtrifluoroacetic acid 50/ 49.5/0.1) is added to cover the bacteria sample spot and dried at room temperature (~ 5 min). MALDI-TOF MS detection was performed on a Bruker microflex ® LRF under linear positive mode. The laser source used in this instrument is a nitrogen laser (337.1 nm). One mass spectrum is obtained from each sample spot by accumulation of 500 laser shots. Each test is repeated for 3 times and the average mass spectrum is presented in all figures. Antibiotic Resistance Results
Non-pathogenic gram-negative E.coli and gram-positive B.subtilis are used as models to investigate the performance of the invented T1O2-MALDI plate for intact bacteria profiling and compare it with a classic bare MALDI plate. Results show that more peaks are obtained from the invented T1O2-MALDI plate, especially at the mass range > 10,000 Da, as shown in Fig. 2 and Fig. 3. The bacterial envelope is mainly composed of lipid bilayers and peptidoglycan, which can be broken up by TiO2-induced photo-chemical redox reactions. The ΉΟ2 nanoparticles also facilitate desorption and ionization of inner components together with the presence of organic matrix. Accordingly, more information about the internal components can be produced by the T1O2-MALDI plate directly from intact bacteria.
Antibiotic-resistant bacteria often contain special resistance genes in their genome or on plasmids, which they have acquired from other bacteria and which they can spread to make non-resistant bacteria resistant to specific antibiotic compounds. Such antibiotic resistance genes encode proteins that perform enzymatic reactions to degrade or modify antibiotic molecules making them non-functional. These proteins conferring resistance to antibiotics normally appear in the mass range higher than 10,000 Da. Ampicillin and kanamycin resistance of E.coli are firstly analysed as models. As shown in Fig. 5b, compared to the ampicillin-susceptible
E.coli XLl-blue strain, an additional peak at m/z 28,970 is detected from the ampicillin-resistant strain, by using the invented Ti02-MALDI plate. This peak comes from a protein called β-lactamase that is responsible for resistance to fi- lactam antibiotics. Similarly, the product of the gene aph (29,050 Da) is detected specially from a kanamycin-resistant strain by using the T1O2-MALDI plate, as shown in Fig. 6b. Neither of these two types of resistance is detectable by using a classic bare MALDI plate, as shown in Fig. 5a and Fig. 6a.
In addition to ampicillin and kanamycin, the resistance of E.coli strains to other antibiotics (e.g. carbenicillin, chloramphenicol, gentamicin, spectinomycin, erythromycin, hygromycin, tetracycline, etc.) can also be detected by the invented plate from intact bacteria.
Example 2 - Detection of Specific Marker from Cancer Cells Using TiOi-modified MALDI Target Plates
Fabrication of a Ti02-modified MALDI target plate is similar to that of Example 1.
The human melanoma cell line wmll5 is employed as model. A cell pellet is collected from culture media by centrifugation (2,000 rpm x 4 min), and resuspended in the same volume of deionized water. The solution (1 pL) is deposited onto a T1O2 spot on the target plate and dried at room temperature. The cells are covered by 1 iL of matrix solution (sinapinic acid, 15 mg/ mL in Vacetonitriie/Vwater/Vtrifiuoroacetic acid 50/49.5/0.1) and dried at room temperature prior MALDI MS detection. MS measurements are similar to those of Example 1.
In-source photo-electrochemical disruption of intact wmll5 happens during MS detection when using the Ti02-modified MALDI plate. Thereafter, more cellular components are detected, especially at the mass range higher than 15,000 Da compared to the result from a classic bare MALDI plate (Fig. 4). The obtained
results imply that the invented T1O2-MALDI plate is more efficient for profiling of intact cancer cells and shows advantage in cellular biomarker detection and differentiation of cancer cells in different growth phases. The green fluorescent protein (GFP, 26,900 Da) is used as a model marker in wmll5 cell line. MS fingerprints from the intact wmll5 cell line with and without the GFP marker by using a classic bare plate (Fig. 7a) and a Ti02-modified plate (Fig. 7b) are compared. It is obvious that the peak from GFP at m/z 26,900 is much more clearly detected with Ti02-modified plate, confirming the potential ability of the invented device for the fast detection of cancer biomarkers.
References:
1. L. F. Marvin, M. A. Roberts, and L. B. Fay, 'Matrix-assisted laser d eso rpti on / i oniza tion time-of-flight mass spectrometry in clinical chemistry', Clin. Chim.
Acta,337 (2003) 11-21.
2. G. Montaudo, F. Samperi, and M.S.Montaudo, 'Characterization of synthetic polymers by MALDI-MS', Prog. Polym. Sci, 31 (2006) 277-357.
3. J. R. Yates, C.I. Ruse, and A. Nakorchevsky, 'Proteomics by Mass Spectrometry: Approaches, Advances, and Applications', Annu. Rev. Biomed. Eng., 11 (2009), 49-79.
4. Q. Liang, J. Sherwood, T. Macher, J. M. Wilson, Y. Bao, and C. J. Cassady, 'Citric Acid Capped Iron Oxide Nanoparticles as an Effective Maldi Matrix for Polymers', /. Am. Soc. Mass Spectrom. , DOI: 10.1007/sl3361-016-1560-4 (2016).
5. A. EI-Aneed, A. Cohen, and J. Banoub, 'Mass spectrometry, review of bascis: electrospray, MALDI, and commonly used mass analyzers', Appl. Spectrosc. Rev., 44
(2009), 210-230.
6. N. Singhal, M. Kumar, P.K. Kanaujia, and J.S. Virdi, 'MALDI-TOF mass spectrometry: an emerging technology for microbial identifictaion and diagnosis', Front. Microbiol., 6 (2015), article 791.
7. K. Chughtai, and R. M. A. Heern, 'Mass spectrometric imaging for biological tissue analysis', Chem. Rev., 110 (2010), 3237-3277.
8. A. Bondarenko, Y. Zhu, L. Qiao, F. Cortes Salazar, H. Pick, and H. H. Girault, 'Aluminium foil as a single-use substrate for MALDI-MS fingerprinting of different melanoma cell lines', Analyst, 141 (2016), 3403-3410.
9. R. D. Holland, J. G. Wilkes, F. Rafii, J. B. Sutherland, C. C. Persons, K. J. Voorhees, and J. O. Lay Jr., 'Rapid Identification of Intact Whole Bacteria Based on Spectral Patterns using Matrix-assisted Laser Desorption/ Ionization with Time-of-f light Mass Spectrometry', Rapid Commun. Mass Spectrom., 10 (1996), 1227-1232.
10. M. A. Claydon, S. N. Davey, V. Edwards-Jones and D. B. Gordon, 'The rapid identification of intact microorganisms using mass spectrometry', Nat. Biotechnol, 14 (1996), 1584-1586.
11. T. Krishnamurthy and P. L. Ross, 'Rapid identification of bacteria by direct matrix- assisted laser desorption/ ionization mass spectrometric analysis of whole cells', Rapid Commun. Mass Spectrom., 1996, 10, 1992-1996.
12. R. Eddabra, G. Prevost, and J.M. Scheftel, 'Rapid Discrimination of Environmental Vibrio by Matrix-Assisted Laser Desorption Ionization Time-of-Flight Mass
Spectrometry.', Microbiol. Res., 167 (2012), 226 - 230.
13. E.N. Ilina, A.D. Borovskaya, M.M. Malakhova, V.A. Vereshchagin, A.A. Kubanova, and A.N. Kruglov, 'Directbacterial Profiling by Matrix- Assistedlaserdesorption-Ionizationtime-of Flight Mass Spectrometry for Identification of Pathogenic Neisseria.', /. Mol. Diagn., 11 (2009), 75-86.
14. M. Drevinek, J. Dresler, J. Klimentova J, L. Pisa, and M. Hubalek, 'Evaluation of sample preparation methods for MALDI-TOF MS identification of highly dangerous bacteria', Lett. Appl. Microbiol, 55 (2012), 40-46.
15. N. Matsuda, M. Matsuda, S. Notake, H. Yokokawa, Y. Kawamura, K. Hiramatsu, and K. Kikuchi, 'Evaluation of a Simple Protein Extraction Method for Species
Identification of Clinically Relevant Staphylococci by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry', /. Clin. Microbiol, 50 (2012), 3862-3866.
16. S. L. Cohen, and B.T. Chait, 'Influence of Matrix Solution Conditions on the MALDI-MS Analysis of Peptides and Proteins', Anal. Chem., 68 (1996), 31-37.
17. X. Liang, K. Zheng, M.G. Qian, and D.M. Lubman, 'Determination of Bacterial
Protein Profiles by Matrixassisted Laser Desorption/ Ionization Mass Spectrometry with High-Performance Liquid Chromatography.', Rapid Commun Mass Spectrom, 10 (1996), 1219-1226.
18. A. Croxatto, G. Prod'hom, and G. Greub, 'Applications of MALDI-TOF mass spectrometry in clinical diagnostic microbiology', FEMS Microbiol. Rev., 36 (2012), 380-407.
19. L. Armelao, D. Barreca, G. Bottaro, A. Gasparotto, C. Maccato, C. Maragno, E. Tondello, U. L. Stangar, M. Bergant, and D. Mahne, Photocatalytic and antibacterial activity of Ti02 and Au/Ti02 nanosystems', Nanotechnology, 18 (2007), 375709.
20. A. Sirelkhatim, S. Mahmud, A. Seeni, N. H. M. Kaus, L. C. Ann, S. K. M. Bakhori, H. Hasan, D. Mohamad, 'Review on Zinc Oxide Nanoparticles: antibacterial activity and toxicity mechanism', Nano-Micro. Lett., 7(2015), 219-242.
21. G. Pradhaban, G. A. Kaliaraj, V. Vishwakarma, 'Antibacterial effects of silver- zirconia composite coatings using pulsed laser deposition onto 316L SS for bio implants',
Prog. Biomater., 3 (2014), 123-130.
22. D. Chandran, L. S. Nair, S. Balachandran, K. R. Babu,M. Deepa, 'Structural, optical, photocatalytic, and antimicrobial activities of cobalt-doped tin oxide nanoparticles', /. Sol-Gel. Set. Technol, 76 (2015), 582-591.
23. R. Nakano, M. Hara, H. Ishiguro, Y. Yao, T. O. K. Nakata, T. Murakami, J. Kajioka,
K. Sunada, K. Hashimoto, A. Fujishima, and Y. Kubota, 'Broad Spectrum Microbicidal Activity of Photocatalysis by TiO , Catalysts, 3 (2013), 310-323.
24. Q. Liang, P. Yang, B. Li, N. Lion, C. Roussel, and H. H. Girault, United States of America Pat. US 8,080,784 B2 (2011).
25. B. Liu, Q. Liang, N. Lion, J. Wan, M. Prudent, C. Roussel, P. Yang, and H. H.
Girault, United States of America Pat. 2010/0248388 Al (2010).
26. C. Liu, R. H. Daniels, R. S. Dubrow, J. L. Gldman, United States of America Pat. US 7,775,038 B2 (2010).
Claims
Claims
1. A plate for matrix-assisted laser desorption ionization (MALDI) mass spectrometry comprising: an electrically conductive substrate partially covered with immobilized photo-reactive nanoparticles, a sample comprising intact biological entities, having envelopes, distributed over the photo-reactive nanoparticles, and a matrix that comprises a light absorber and a charge carrier acid, the plate facilitating in-source photo-electrochemical disruption of the envelopes and desorption and ionization of components of the entities.
2. A plate according to claim 1 wherein the sample comprises at least one of microorganisms (e.g., bacteria, fungi, yeasts, virus), cells (e.g., cancer cells) or tissues.
3. A plate according to claim 1 or 2 wherein the nanoparticles comprise metal oxides (e.g., Ί1Ο2, ZnO, Zr02, Sn02), or metal oxides doped with different metal species (e.g., Au, Ag, Co).
4. A plate according to claim 1, 2 or 3 wherein the nanoparticles are made of metals that are oxidized on their surface to form a thin layer of metallic oxides.
5. A plate according to any preceding claim wherein the nanoparticles are spherical or cylindrical with a mean radius between 1.5 and 50 nanometers.
6. A plate according to any preceding claim wherein the nanoparticles are deposited on the substrate in a pattern selected from a specific area, a set of stripes, and an array of individual spots.
7. A plate according to any preceding claims wherein the nanoparticles are immobilized in a layer of thickness ranging from 50 nanometres to 50 micrometres.
8. A plate according to any preceding claims wherein the electrically conductive substrate comprises stainless steel, aluminium, nickel, zinc, copper, silicon, tin- indium oxide on glass or a conductive/ semi-conductive polymer.
9. A method of preparing the plate according to any preceding claim comprising the steps of: (a) preparing a suspension of nanoparticles according to one of claims 3, 4
and 5, and (b) applying this suspension to the conductive substrate, according to claim 6 or 7.
10. A method according to claims 9, wherein the suspension of nanoparticles is deposited on the substrate by inkjet-printing, screen-printing, rotogravure printing, drop casting or another deposition technique.
11. A method according to claim 9 or 10, comprising the step of thermal or photonic flash curing in order to obtain sintering of the nanoparticles to ensure their mutual adhesion and their adhesion to the substrate.
13. A method of use of a plate according to any one of claims 1 to 8, wherein components are released from the intact biological entities for the mass spectrometry analysis by photo-electrochemical disruption of the intact biological entities' envelope structure.
14. A method according to claim 12, wherein the components released from the intact biological entities for mass spectrometry analysis are biomolecules, such as lipids, proteins, peptides, nucleic acids and metabolites.
15. A method according to claim 13, wherein the components released for mass spectrometry analysis are proteins, which are specific markers for detection of micro-organisms antibiotic resistance, when the intact biological entities include intact bacteria, fungi, viruses, yeasts, etc.
16. A method according to claim 13, wherein the components released for mass spectrometry analysis are biomolecules that are specific cancer markers, when the intact biological entities include cancer cells or cancer tissues.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1700908.5 | 2017-01-19 | ||
GBGB1700908.5A GB201700908D0 (en) | 2017-01-19 | 2017-01-19 | Maldi device and methods of preparation and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2018134232A1 true WO2018134232A1 (en) | 2018-07-26 |
Family
ID=58462970
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2018/051080 WO2018134232A1 (en) | 2017-01-19 | 2018-01-17 | Maldi device and methods of preparation and use thereof |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB201700908D0 (en) |
WO (1) | WO2018134232A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023157352A1 (en) * | 2022-02-16 | 2023-08-24 | 浜松ホトニクス株式会社 | Specimen support, ionization method, and mass spectrometry method |
CN117074503A (en) * | 2023-10-16 | 2023-11-17 | 成都泰莱医学检验实验室有限公司 | Nanocomposite for time-of-flight mass spectrometry detection and preparation method thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060145068A1 (en) * | 2004-12-30 | 2006-07-06 | Yu-Chie Chen | Metal oxide-assisted laser desorption/ionization mass spectrometry |
WO2006118595A2 (en) * | 2004-09-17 | 2006-11-09 | Nanosys, Inc. | Nanostructured thin films and their uses |
WO2009003673A2 (en) * | 2007-07-02 | 2009-01-08 | École Polytechnique Fédérale de Lausanne | Solid phase extraction and ionization device |
-
2017
- 2017-01-19 GB GBGB1700908.5A patent/GB201700908D0/en not_active Ceased
-
2018
- 2018-01-17 WO PCT/EP2018/051080 patent/WO2018134232A1/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006118595A2 (en) * | 2004-09-17 | 2006-11-09 | Nanosys, Inc. | Nanostructured thin films and their uses |
US20060145068A1 (en) * | 2004-12-30 | 2006-07-06 | Yu-Chie Chen | Metal oxide-assisted laser desorption/ionization mass spectrometry |
WO2009003673A2 (en) * | 2007-07-02 | 2009-01-08 | École Polytechnique Fédérale de Lausanne | Solid phase extraction and ionization device |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023157352A1 (en) * | 2022-02-16 | 2023-08-24 | 浜松ホトニクス株式会社 | Specimen support, ionization method, and mass spectrometry method |
CN117074503A (en) * | 2023-10-16 | 2023-11-17 | 成都泰莱医学检验实验室有限公司 | Nanocomposite for time-of-flight mass spectrometry detection and preparation method thereof |
CN117074503B (en) * | 2023-10-16 | 2024-01-26 | 成都泰莱医学检验实验室有限公司 | Nanocomposite materials for time-of-flight mass spectrometry detection and preparation methods thereof |
Also Published As
Publication number | Publication date |
---|---|
GB201700908D0 (en) | 2017-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Bouschen et al. | Matrix vapor deposition/recrystallization and dedicated spray preparation for high‐resolution scanning microprobe matrix‐assisted laser desorption/ionization imaging mass spectrometry (SMALDI‐MS) of tissue and single cells | |
TWI434314B (en) | Substrate for mass spectrometry, mass spectrometry, and mass spectrometer | |
US6617575B1 (en) | Modified ion source targets for use in liquid maldi MS | |
US6995363B2 (en) | Reduction of matrix interference for MALDI mass spectrometry analysis | |
Naito et al. | A novel laser desorption/ionization method using through hole porous alumina membranes | |
Sonderegger et al. | Surface-assisted laser desorption/ionization-mass spectrometry using TiO 2-coated steel targets for the analysis of small molecules | |
McEwen et al. | An alternative ionization paradigm for atmospheric pressure mass spectrometry: flying elephants from Trojan horses | |
CN103592361B (en) | The application of a kind of tungsten disulfide in laser desorption ionisation Mass Spectrometer Method | |
Hsu et al. | Desorption ionization of biomolecules on metals | |
US20100248388A1 (en) | Solid Phase Extraction and Ionization Device | |
US8217340B2 (en) | Mass spectrometry substrate and mass spectrometry method | |
US9799501B2 (en) | Sample mounting plate | |
US20210343518A1 (en) | Multi-mode ionization apparatus and uses thereof | |
KR101592517B1 (en) | Substrate for Laser Desorption Ionization Mass Spectrometry and method for manufacturing the same | |
US9709583B2 (en) | MALDI/SELDI analysis of complex mixtures comprising hydrophilic and hydrophobic analytes | |
Lee et al. | Nanoengineered micro gold shells for LDI-TOF analysis of small molecules | |
JP5317054B2 (en) | Mass spectrometry substrate, method for producing the same, and mass spectrometry | |
US8080784B2 (en) | Ionization device | |
CN107167512A (en) | Disposable target plate for substance assistant laser desorpted ionisation mass spectrometry | |
WO2018134232A1 (en) | Maldi device and methods of preparation and use thereof | |
Kuwata et al. | DIUTHAME enables matrix‐free mass spectrometry imaging of frozen tissue sections | |
Kosyakov et al. | Carbon nanocoatings: A new approach to recording mass spectra of low-molecular compounds using surface-assisted laser desorption/ionization mass spectrometry | |
JP6363527B2 (en) | Sample loading plate | |
US9552972B2 (en) | Method for ion production | |
Kononikhin et al. | Signal enhancement in electrospray laser desorption/ionization mass spectrometry by using a black oxide-coated metal target and a relatively low laser fluence |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 18700759 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 18700759 Country of ref document: EP Kind code of ref document: A1 |